Brief: Aslan Pharmaceuticals Ltd Files For Offering Of Up To $21.5 Mln Of ADS - SEC Filing
13/09/2022 21:10
Sept 13 (Reuters) - Aslan Pharmaceuticals Ltd 7A9y.F :
* ASLAN PHARMACEUTICALS LTD FILES FOR OFFERING OF UP TO
$21.5
MILLION OF ADS REPRESENTING ORDINARY SHARES - SEC FILING
Further company coverage: 7A9y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aslan Pharmaceuticals
See all newsBrief: Aslan Pharmaceuticals Announces Plan To Implement ADS Ratio Change
Brief: Aslan Pharmaceuticals Ltd Files For Shelf Of Up To 61.9 Million Ordinary Shares By Selling Stockholder - SEC Filing
Brief: Aslan Pharmaceuticals Announces Expansion Of Its Collaboration With Zenyaku
Brief: Aslan Pharmaceuticals Announces Positive Interim Results From Phase 2 Study Of Eblasakimab
Brief: ASLAN Pharmaceuticals To Sell ADSs Having An Aggregate Offering Price Of Up To $12 Mln